Karus Therapeutics
About:
Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.
Website: https://karustherapeutics.com/
Twitter/X: karustx
Top Investors: IP Group, Novo Holdings, SV Health Investors, New Leaf Venture Partners, Esperante Ventures
Description:
Karus is an emerging pharmaceutical company whose R&D activities are focused on the design and development of innovative, molecular-targeted, small molecule drugs to treat immune/inflammatory disorders and cancer.
$14.8M
$10M to $50M
Chilworth, Hampshire, United Kingdom
2005-01-01
info(AT)karustherapeutics.com
Paul Townsend
11-50
2016-05-05
Private
© 2025 bioDAO.ai